These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4910597)

  • 1. Successful long term inhibition of xenograft rejection.
    Cerilli GJ; Gideon L
    Surg Forum; 1969; 20():284-5. PubMed ID: 4910597
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of immunosuppression and cellular antigen on xenograft survival.
    Cerilli J; Gideon L; Hattan D
    Transplant Proc; 1970 Dec; 2(4):516-21. PubMed ID: 4939699
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-species transplantation in embryonic and neonatal animals.
    Steinmuller D
    Transplant Proc; 1970 Dec; 2(4):438-45. PubMed ID: 4939692
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum.
    Donawick WJ; Shaffer CF; Dodd DC; Buchanan JW; Fregin GF
    Transplant Proc; 1971 Mar; 3(1):551-3. PubMed ID: 4937937
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal and skin xenografts from baboons to macaques: effect of antilymphocyte globulins.
    Dubernard JM; Bonneau M; Bomel J; Montagard J; Blitz M; Latour M; Blanc-Brunat N; Fries D; Brochard JC; Bansillon V; Bansillon G; Capodicasa G
    Transplant Proc; 1971 Mar; 3(1):545-50. PubMed ID: 4999462
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term skin allograft survical elicited by a finite treatment with antilymphocyte serum combined with cytarabine.
    Perper RJ; Monovich RE; Bowersox BE
    J Immunol; 1970 May; 104(5):1063-71. PubMed ID: 4910473
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effects of cytosine arabinoside combined with antilymphocyte globulin for suppressing xenograft rejection.
    Gunnarsson A; Moberg AW; Gewurz H; Perper RJ; Najarian JS
    Surg Forum; 1969; 20():263-5. PubMed ID: 4192212
    [No Abstract]   [Full Text] [Related]  

  • 9. Dependence of antilymphocyte serum effectiveness on degree of donor-recipient histocompatibility.
    Silberman H; Reckard CR; Klinman N; Barker CF
    Surg Forum; 1972; 23(0):303-5. PubMed ID: 4601092
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive enhancement of skin heterografts.
    Jeekel J; Westbroek DL
    Transplant Proc; 1971 Mar; 3(1):714-6. PubMed ID: 4937964
    [No Abstract]   [Full Text] [Related]  

  • 11. The xenograft rejection phenomenon. I. Response of the mouse to rabbit, guinea pig and rat skin xenografts.
    Ben-Hur N; Solowey AC; Rapaport FT
    Isr J Med Sci; 1969; 5(1):1-12. PubMed ID: 4894300
    [No Abstract]   [Full Text] [Related]  

  • 12. The xenograft rejection phenomenon. II. Response of the guinea pig to mouse, rat and rabbit skin xenografts.
    Ben-Hur N; Solowey AC; Rapaport FT
    Isr J Med Sci; 1969; 5(3):322-31. PubMed ID: 4898220
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterotransplantation.
    Reemtsma K
    Transplant Proc; 1969 Mar; 1(1):251-5. PubMed ID: 5002658
    [No Abstract]   [Full Text] [Related]  

  • 14. The Cape Western baboon in organ allotransplantation.
    Murphy GP; Brede HD; Cohen E; Grace JT
    Transplant Proc; 1970 Dec; 2(4):546-9. PubMed ID: 5000235
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
    Vizler C; Jánossy T; Tabi Z; Végh P
    Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat.
    Sachs DH; Winn HJ; Russell PS
    J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of ovarian graft survival in mature rats.
    Yussman MA; Hines EC
    Surg Forum; 1969; 20():406-8. PubMed ID: 4910616
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term survival and use of human skin xenografts in immunosuppressed mice.
    Jánossy T; Vizler C; Krizsa J; Hunyadi J; Kiss M; Nyirati I; Dobozy A; Végh P
    Transplant Proc; 1994 Jun; 26(3):1268-70. PubMed ID: 8029904
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of guinea pig skin grafts in the brains of rats under treatment with antilymphocytic serum.
    Ridley A
    Transplantation; 1970 Jul; 10(1):86-91. PubMed ID: 4912989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.